AFX Carl Zeiss Meditec AG

DGAP-News: Carl Zeiss Meditec AG: Postponement of the Annual General Meeting 2020 in the course of tightening up the regulations for public events

DGAP-News: Carl Zeiss Meditec AG / Key word(s): AGM/EGM
Carl Zeiss Meditec AG: Postponement of the Annual General Meeting 2020 in the course of tightening up the regulations for public events

17.03.2020 / 10:38
The issuer is solely responsible for the content of this announcement.


Carl Zeiss Meditec AG: Postponement of the Annual General Meeting 2020 in the course of tightening up the regulations for public events
 
 

JENA, 17 March 2020

On the basis of the decree of the President of the State Administration Office of Thuringia (Landesverwaltungsamt Thüringen) of 14 March 2020, according to which "events and meetings of people with 50 or more persons must be prohibited from now until further notice", the Management Board of Carl Zeiss Meditec AG has decided to postpone the Annual General Meeting, which was scheduled for Tuesday, 24 March 2020 (published in the Federal Gazette (Bundesanzeiger) of 11 February 2020); it will therefore not take place. A new date will be announced in time.

 

Contact for investors and press

Sebastian Frericks
Director Investor Relations, Carl Zeiss Meditec AG
Tel. 03641 220-116
E-Mail:



17.03.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


Language: English
Company: Carl Zeiss Meditec AG
Göschwitzer Str. 51-52
07745 Jena, Germany
Germany
Phone: +49 (0)3641 220-0
Fax: +49 (0)3641 220-112
E-mail:
Internet: /meditec-ag/ir
ISIN: DE0005313704
WKN: 531370
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 999125

 
End of News DGAP News Service

999125  17.03.2020 

fncls.ssp?fn=show_t_gif&application_id=999125&application_name=news&site_id=research_pool
EN
17/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Carl Zeiss Meditec AG

Q1/26 schwach – ohne schnelle Verbesserung stärkere Sanierung

Die 26er Guidance (s.u.) wurde am 22.01.26 ausgesetzt. Eine aktualisierte Prognose soll spätestens zum 12.05.26 (H1/26-Report) veröffentlicht werden. Die Konsensusanpassungen sind u.E. noch nicht erfolgt;

Q1/26 weak – stronger restructuring without rapid improvement

The 26 guidance (see below) was suspended on 22.01.26. An updated forecast is to be published by 06.05.26 (H1/26 report) at the latest. In our opinion, the consensus adjustments have not yet been made; in our opinion, the share price already reflects a halving of profits in FY26.

Thomas J. Schiessle
  • Thomas J. Schiessle

Interim CEO kassiert 26er-Guidance

Die 26er Guidance wird laut adhoc Meldung vom 22.01.26 „voraussichtlich nicht erreicht werden“. Gründe hierfür sind: Ein zunehmend schwächeres Investitionsumfeld in der Region Americas; ein schwächeres Konsumenten-geschäft in China rund um das chinesische Neujahrsfest. Zusätzlich belastend sind in China Volumens-Rückgänge bei einem zugeteilten IOL-Tender und erwarteter Preisdruck bei einem bevorstehenden IOL-Tender. Geopolitische Unsicherheiten und Handelsbarrieren und FX-Gegenwind kommen hinzu....

Thomas J. Schiessle
  • Thomas J. Schiessle

Interim CEO misses FY26 guidance

According to an ad-hoc report dated 01/22/26, the 26 guidance is "unlikely to be achieved." The reasons for this are: an increasingly weaker investment environment in the Americas region; weaker consumer business in China around the Chinese New Year. Additionally burdensome in China are volume declines in an allocated IOL tender and expected price pressure in an upcoming IOL tender. Geopolitical uncertainties, trade barriers, and FX headwinds also complicate matters. A revised forecast is expe...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch